Adropin – Potential Link in Cardiovascular Protection for Obese Male Type 2 Diabetes Mellitus Patients Treated with Liraglutide

Adropin – Potential Link in Cardiovascular Protection for Obese Male Type 2 Diabetes Mellitus Patients Treated with Liraglutide

The aim of this study was to determine plasma adropin concentration and parameters of insulin resistance in obese male type 2 diabetes mellitus (T2DM) patients before and after 3-month liraglutide treatment. In this interventional study, we enrolled 15 obese male T2DM patients with body mass index (...

Full description

Bibliographic Details
Main Authors: Tina Tičinović Kurir, Tanja Miličević, Anela Novak, Marino Vilović, Joško Božić
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2020-01-01
Series:Acta Clinica Croatica
Subjects:
Diabetes mellitus type 2
Insulin resistance
Obesity
Adropin
Liraglutide
Endothelial cell dysfunction
Online Access:https://hrcak.srce.hr/file/354165

Similar Items

Similar Items